ATE219931T1 - Darmlösliche grannulatkörner enthaltende tablette - Google Patents

Darmlösliche grannulatkörner enthaltende tablette

Info

Publication number
ATE219931T1
ATE219931T1 AT94929012T AT94929012T ATE219931T1 AT E219931 T1 ATE219931 T1 AT E219931T1 AT 94929012 T AT94929012 T AT 94929012T AT 94929012 T AT94929012 T AT 94929012T AT E219931 T1 ATE219931 T1 AT E219931T1
Authority
AT
Austria
Prior art keywords
tablet
granules
enteric
tableting
reduced
Prior art date
Application number
AT94929012T
Other languages
English (en)
Inventor
Tomohisa Matsushita
Mitsuo Hashimoto
Original Assignee
Mitsubishi Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Pharma Corp filed Critical Mitsubishi Pharma Corp
Application granted granted Critical
Publication of ATE219931T1 publication Critical patent/ATE219931T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT94929012T 1993-10-12 1994-10-06 Darmlösliche grannulatkörner enthaltende tablette ATE219931T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP25404993 1993-10-12
PCT/JP1994/001675 WO1995010264A1 (en) 1993-10-12 1994-10-06 Tablet containing enteric granules

Publications (1)

Publication Number Publication Date
ATE219931T1 true ATE219931T1 (de) 2002-07-15

Family

ID=17259525

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94929012T ATE219931T1 (de) 1993-10-12 1994-10-06 Darmlösliche grannulatkörner enthaltende tablette

Country Status (12)

Country Link
US (1) US5798120A (de)
EP (1) EP0723777B1 (de)
JP (1) JP3710473B2 (de)
KR (1) KR100353384B1 (de)
AT (1) ATE219931T1 (de)
AU (1) AU683092B2 (de)
CA (1) CA2173506C (de)
DE (1) DE69430921T2 (de)
DK (1) DK0723777T3 (de)
ES (1) ES2179079T3 (de)
PT (1) PT723777E (de)
WO (1) WO1995010264A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9600857A (es) * 1994-07-08 1997-06-28 Astra Ab Forma de dosificacion i en tabletas, con unidades multiples.
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
SE9500422D0 (sv) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
SE9600072D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients II
SE9600071D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
SE512835C2 (sv) * 1996-01-08 2000-05-22 Astrazeneca Ab Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
WO1998023272A1 (en) * 1996-11-27 1998-06-04 The Procter & Gamble Company Compositions and methods for the treatment of gastrointestinal disorders
JP3870470B2 (ja) * 1997-02-07 2007-01-17 大正製薬株式会社 マルチプルユニットタイプ徐放性錠剤
US6174548B1 (en) 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6096340A (en) * 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
KR20010034770A (ko) 1998-04-17 2001-04-25 우에하라 아끼라 멀티플 유닛 타입 서방성 정제
AU3731699A (en) 1998-05-18 1999-12-06 Takeda Chemical Industries Ltd. Orally disintegrable tablets
AU4802099A (en) * 1998-07-28 2000-02-21 Takeda Chemical Industries Ltd. Rapidly disintegrable solid preparation
US6733778B1 (en) 1999-08-27 2004-05-11 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6544556B1 (en) 2000-09-11 2003-04-08 Andrx Corporation Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
WO2004073654A2 (en) * 2003-02-20 2004-09-02 Santarus, Inc. A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained supression of gastric acid
KR20050123096A (ko) * 2003-02-24 2005-12-29 미쯔비시 웰 파마 가부시키가이샤 테나토프라졸의 거울상 이성질체 및 치료를 위한 그 용도
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US7670624B2 (en) * 2004-01-29 2010-03-02 Astella Pharma Inc. Gastrointestinal-specific multiple drug release system
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
SI2007362T1 (sl) 2006-04-04 2018-12-31 Kg Acquisition Llc Peroralne odmerne oblike, ki vključujejo antitrombocitno sredstvo in inhibitor kisline
EP2026768B1 (de) * 2006-06-01 2018-02-28 Dexcel Pharma Technologies Ltd. Pharmazeutische formulierung auf mehreren einheiten
JP5041774B2 (ja) * 2006-09-22 2012-10-03 日本ケミファ株式会社 メサラジンを有効成分として含有する徐放性錠剤
JP4329947B1 (ja) * 2009-01-20 2009-09-09 ライオン株式会社 内服用錠剤
CN102198131A (zh) * 2010-03-24 2011-09-28 济南瑞安药业发展有限公司 一种含有奥美拉唑的新的复方制剂
PE20140005A1 (es) * 2010-12-03 2014-01-23 Takeda Pharmaceutical Tableta oralmente desintegradora
WO2016174664A1 (en) 2015-04-29 2016-11-03 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB971486A (en) * 1960-04-01 1964-09-30 Rech S Pharma Et Scient Therapeutic compositions comprising aspirin and polysiloxanes
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
CA1259924A (en) * 1985-03-25 1989-09-26 Wallace E. Becker Pharmaceutical tableting method
CA1327010C (en) * 1986-02-13 1994-02-15 Tadashi Makino Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production
JPH0780754B2 (ja) * 1986-08-06 1995-08-30 エーザイ株式会社 多顆粒型持続性錠剤
JP2514078B2 (ja) * 1988-08-22 1996-07-10 エスエス製薬株式会社 圧縮成型製剤
JP2781442B2 (ja) * 1990-02-19 1998-07-30 旭化成工業株式会社 顆粒含有錠剤
JP2856485B2 (ja) * 1990-03-07 1999-02-10 旭化成工業株式会社 顆粒含有錠

Also Published As

Publication number Publication date
US5798120A (en) 1998-08-25
EP0723777A1 (de) 1996-07-31
EP0723777B1 (de) 2002-07-03
EP0723777A4 (de) 1997-06-25
JP3710473B2 (ja) 2005-10-26
AU683092B2 (en) 1997-10-30
DK0723777T3 (da) 2002-10-28
AU7822294A (en) 1995-05-04
KR960704531A (ko) 1996-10-09
ES2179079T3 (es) 2003-01-16
PT723777E (pt) 2002-11-29
DE69430921D1 (de) 2002-08-08
CA2173506A1 (en) 1995-04-20
CA2173506C (en) 2006-05-09
KR100353384B1 (ko) 2002-12-28
WO1995010264A1 (en) 1995-04-20
DE69430921T2 (de) 2003-02-13

Similar Documents

Publication Publication Date Title
ATE219931T1 (de) Darmlösliche grannulatkörner enthaltende tablette
US3074852A (en) Pharmaceuticals with delayed release
EP0049061B1 (de) Arzneizubereitung
ES2262528T3 (es) Composiciones medicinales estables para administracion oral que utilizan oxidos de hierro.
AU624117B2 (en) Pharmaceutical compositions having good stability
AU770777B2 (en) Multilayered tablet for administration of a fixed combination of tramadol and diclofenac
IL72664A (en) Controlled release pharmaceutical compositions comprising cross-linked,porous polymers
KR890016968A (ko) 약제 흡착물
JO2555B1 (en) Forms of oral doses of propiferine or pharmaceutically acceptable salts thereof with an extended release of active agent
KR910004180A (ko) 저작성 약제학적 정제를 제조하기 위한 회전과립화 공정 및 맛을 은폐하기 위한 피복공정
EP0103387A3 (de) Langwirkende Matrix-Tabletten-Formulierungen
IE821861L (en) Pharmaceutical compositions
NO865195L (no) FremgangsmŸte for fremstilling av et retardpreparat av ibuprofen.
CA2383212A1 (en) Controlled release oral dosage suitable for oral administration
US5230901A (en) Sustained release tablet of a mixture of alginates and polyacrylates
EP0106028A3 (de) Diuretische/blutdrucksenkende Zusammensetzungen und Verfahren zu ihrer Herstellung
US6099860A (en) Controlled release oral preparation with naproxen sodium and pseudoephedrine
JP2001187738A (ja) アスピリン含有製剤製品
RU96123569A (ru) Лекарственный препарат
GB1297719A (de)
NZ569218A (en) Medicinal Blister Pack for tablets containing Phenothiazine derivatives
WO2004028507A1 (en) Method to improve pharmaceutical tablets having a matrix of cellulose ether

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification